Detalles de la búsqueda
1.
Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax Meningitis.
Clin Infect Dis
; 2024 Feb 27.
Artículo
Inglés
| MEDLINE | ID: mdl-38412060
2.
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens.
Antimicrob Agents Chemother
; 68(4): e0140023, 2024 Apr 03.
Artículo
Inglés
| MEDLINE | ID: mdl-38415667
3.
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics.
Antimicrob Agents Chemother
; 68(2): e0139323, 2024 Feb 07.
Artículo
Inglés
| MEDLINE | ID: mdl-38169309
4.
Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models.
Antimicrob Agents Chemother
; 68(3): e0139423, 2024 Mar 06.
Artículo
Inglés
| MEDLINE | ID: mdl-38289076
5.
Comprehensive stability analysis of 13 ß-lactams and ß-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation.
Antimicrob Agents Chemother
; 68(3): e0139923, 2024 Mar 06.
Artículo
Inglés
| MEDLINE | ID: mdl-38329330
6.
CDC Guidelines for the Prevention and Treatment of Anthrax, 2023.
MMWR Recomm Rep
; 72(6): 1-47, 2023 11 17.
Artículo
Inglés
| MEDLINE | ID: mdl-37963097
7.
Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems Pharmacology.
Antimicrob Agents Chemother
; 67(6): e0160322, 2023 06 15.
Artículo
Inglés
| MEDLINE | ID: mdl-37199612
8.
Individual Components of Polymyxin B Modeled via Population Pharmacokinetics to Design Humanized Dosage Regimens for a Bloodstream and Lung Infection Model in Immune-Competent Mice.
Antimicrob Agents Chemother
; 67(5): e0019723, 2023 05 17.
Artículo
Inglés
| MEDLINE | ID: mdl-37022153
9.
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance.
Antimicrob Agents Chemother
; 67(8): e0041423, 2023 08 17.
Artículo
Inglés
| MEDLINE | ID: mdl-37428034
10.
Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal Sprays.
Mol Pharm
; 20(11): 5690-5700, 2023 11 06.
Artículo
Inglés
| MEDLINE | ID: mdl-37773975
11.
Central and peripheral lung deposition of fluticasone propionate dry powder inhaler formulations in humans characterized by population pharmacokinetics.
Pharm Res
; 40(5): 1177-1191, 2023 May.
Artículo
Inglés
| MEDLINE | ID: mdl-37081302
12.
Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.
Clin Infect Dis
; 75(Suppl 3): S379-S391, 2022 10 17.
Artículo
Inglés
| MEDLINE | ID: mdl-36251546
13.
Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.
Antimicrob Agents Chemother
; 66(3): e0220321, 2022 03 15.
Artículo
Inglés
| MEDLINE | ID: mdl-35041509
14.
Mechanistic Insights to Combating NDM- and CTX-M-Coproducing Klebsiella pneumoniae by Targeting Cell Wall Synthesis and Outer Membrane Integrity.
Antimicrob Agents Chemother
; 66(9): e0052722, 2022 09 20.
Artículo
Inglés
| MEDLINE | ID: mdl-35924913
15.
Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
J Antimicrob Chemother
; 77(2): 356-363, 2022 02 02.
Artículo
Inglés
| MEDLINE | ID: mdl-34668007
16.
Synthesis and Structure-Activity Relationship of Thioacetamide-Triazoles against Escherichia coli.
Molecules
; 27(5)2022 Feb 24.
Artículo
Inglés
| MEDLINE | ID: mdl-35268619
17.
Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae.
Antimicrob Agents Chemother
; 65(9): e0069221, 2021 08 17.
Artículo
Inglés
| MEDLINE | ID: mdl-34152820
18.
Emergence of Resistance to Ceftazidime-Avibactam in a Pseudomonas aeruginosa Isolate Producing Derepressed blaPDC in a Hollow-Fiber Infection Model.
Antimicrob Agents Chemother
; 65(6)2021 05 18.
Artículo
Inglés
| MEDLINE | ID: mdl-33782013
19.
FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development.
Antimicrob Agents Chemother
; 65(1)2020 12 16.
Artículo
Inglés
| MEDLINE | ID: mdl-33106262
20.
First Penicillin-Binding Protein Occupancy Patterns for 15 ß-Lactams and ß-Lactamase Inhibitors in Mycobacterium abscessus.
Antimicrob Agents Chemother
; 65(1)2020 12 16.
Artículo
Inglés
| MEDLINE | ID: mdl-33106266